Lipid lowering effect of fulvestrant in hormone-sensitive metastatic breast cancer patients

被引：0
|
作者：
Camerini, A.
Amoroso, D.
Garrone, O.
Vincenti, M.
Tartarelli, G.
Donati, S.
Valsuani, C.
Siclari, O.
Mattiot, V. Polla
Sgambato, A.
机构：
[1] Osped Versilia, Lido Di Camaiore, LU, Italy
[2] Ist Toscano Tumori, Lido Di Camaiore, LU, Italy
[3] Osped Santa Croce, Cuneo, Italy
[4] Osped Inferm Biella, Biella, Italy
[5] Univ Cattolica, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Fulvestrant for hormone-sensitive metastatic breast cancer
    Lee, Clara I.
    Goodwin, Annabel
    Wilcken, Nicholas
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [2] Effect of fulvestrant on lipid profile in hormone-sensitive advanced breast cancer patients
    Camerini, Andrea
    Amoroso, Domenico
    Garrone, Omella
    Valsuani, Chiara
    Tartarelli, Gianna
    Porta, Romana Prosperi
    Siclari, Olimpia
    Donati, Sara
    Puccetti, Cheti
    Sgambato, Alessandro
    ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [3] Effect of fulvestrant treatment on complete blood lipid profile in hormone-sensitive metastatic breast cancer patients
    Camerini, Andrea
    Amoroso, Domenico
    Garrone, Ornella
    Donati, Sara
    Tartarelli, Gianna
    Vincenti, Maura
    Valsuani, Chiara
    Siclari, Olimpia
    Puccetti, Cheti
    Porta, Romana Prosperi
    Rondini, Marianna
    Pronzato, Paolo
    Sgambato, Alessandro
    ANNALS OF ONCOLOGY, 2007, 18 : 47 - 47
  • [4] Effect of fulvestrant treatment on serum VEGF levels in hormone-sensitive metastatic breast cancer patients
    Camerini, A.
    Garrone, O.
    Valsuani, C.
    Puccetti, C.
    Rondini, M.
    Donati, S.
    Siclari, O.
    Barni, S.
    Pronzato, P.
    Amoroso, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Fulvestrant in the paliative treatment of hormone-sensitive breast Cancer
    Kolasinska-Cwikla, Agnieszka
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : F5 - F7
  • [6] EFFECT OF FULVESTRANT TREATMENT ON SERUM VEGF LEVELS IN HORMONE-SENSITIVE ADVANCED BREAST CANCER PATIENTS
    Camerini, A.
    Garrone, O.
    Valsuani, C.
    Tartarelli, G.
    Porta, R. Prosperi
    Siclari, O.
    Rondini, M.
    Puccetti, C.
    Donati, S.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2009, 20 : 47 - 47
  • [7] Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study
    Hyams, David M.
    Chan, Arlene
    de Oliveira, Celia
    Snyder, Raymond
    Vinholes, Jeferson
    Audeh, M. William
    Alencar, Victor M.
    Lombard, Janine
    Mookerjee, Bijoyesh
    Xu, John
    Brown, Kathryn
    Klein, Paula
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1345 - 1354
  • [8] Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study
    David M. Hyams
    Arlene Chan
    Celia de Oliveira
    Raymond Snyder
    Jeferson Vinholes
    M. William Audeh
    Victor M. Alencar
    Janine Lombard
    Bijoyesh Mookerjee
    John Xu
    Kathryn Brown
    Paula Klein
    Investigational New Drugs, 2013, 31 : 1345 - 1354
  • [9] Cediranib in Combination with Fulvestrant in Hormone-Sensitive Metastatic Breast Cancer: A Phase II Randomized Study.
    Hyams, D. M.
    de Oliveira, C.
    Snyder, R.
    Klein, P.
    Vinholes, J.
    Audeh, M. W.
    Alencar, V
    Lombard, J.
    Mookerjee, B.
    Xu, J.
    Chan, A.
    CANCER RESEARCH, 2009, 69 (24) : 511S - 511S
  • [10] Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer
    Bodmer, Alexandre
    Castiglione-Gertsch, Monica
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S28 - S37
12345